Last updated: 2026-10-12 20:28:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
ADARx Pharmaceuticals, Inc. (ADRX) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $17.92, with a market capitalization of $1.90B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $16.64 to $23.21. This page covers its latest market performance, valuation, price trends and company information.
$1.90B | |
$17.78 | |
$30.87 | |
$12.74 | |
$17.78 | |
302.43K | |
1.20M | |
-- | |
$23.21 | |
$16.64 | |
-- | |
-- |
ADARx Pharmaceuticals, Inc. (ADRX) is trading at $17.80 in after-hours trading as of 2026-10-12 19:59:59, up 0.12% ($0.02) from the regular-session close of $17.78.
After-hours trading shows how investors are pricing ADRX after the regular session closes. The current after-hours price is near the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, ADARx Pharmaceuticals, Inc. (ADRX) moved from $19.54 to $17.92, representing a decline of 8.30% ($1.62).
The stock traded between $16.64 and $20.77 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 808.93 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 19.5%
ADRX is currently trading at $17.92, placing it 19.5% of the way from its 52-week low of $16.64 to its 52-week high of $23.21. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Adarx Pharmaceuticals Inc is a late-clinical stage biotechnology company focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases. Its pipeline includes three clinical-stage programs and two advanced preclinical programs. The three hepatic-targeted programs are agazisiran, onvuzosiran, and ADX-626, while the two extrahepatic-targeted programs are ADX-077 and ADX-199.
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of ADARx Pharmaceuticals, Inc. (ADRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.